Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
| Actual shortage: | 249 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Resolved | 2021-04-29 | 2021-08-07 | 138291 |
| TEVA-LENOLTEC NO. 3 | 300MG 30MG 15MG | TABLET | Resolved | 2021-04-29 | 2021-05-06 | 138288 |
| TEVA-LENOLTEC NO. 2 | 15MG 15MG 300MG | TABLET | Resolved | 2021-04-29 | 2021-06-10 | 138285 |
| ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2021-04-29 | 2021-07-09 | 138282 |
| TEVA-VALSARTAN | 320MG | TABLET | Actual shortage | 2021-04-22 | 2021-04-22 | 137939 |
| TEVA-VALSARTAN | 160MG | TABLET | Resolved | 2021-04-22 | 2023-06-09 | 137936 |
| TEVA-VALSARTAN | 80MG | TABLET | Actual shortage | 2021-04-22 | 2024-01-08 | 137933 |
| TEVA-VALSARTAN | 40MG | TABLET | Actual shortage | 2021-04-22 | 2021-04-22 | 137930 |
| ACT PIOGLITAZONE | 30MG | TABLET | Resolved | 2021-04-21 | 2022-04-28 | 137905 |
| TEVA-LOSARTAN | 100MG | TABLET | Resolved | 2021-04-21 | 2024-04-01 | 137902 |
| TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2021-04-21 | 2024-04-01 | 137899 |
| TEVA-FLUOXETINE | 20MG | CAPSULE | Resolved | 2021-04-21 | 2021-06-03 | 137896 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2021-04-21 | 2021-05-13 | 137893 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2021-04-21 | 2021-05-20 | 137890 |
| TEVA-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2021-04-21 | 2021-07-29 | 137885 |
| ACT PIOGLITAZONE | 15MG | TABLET | Resolved | 2021-04-21 | 2022-04-28 | 137882 |
| TEVA-SERTRALINE | 50MG | CAPSULE | Resolved | 2021-04-15 | 2021-04-21 | 137547 |
| TEVA-OMEPRAZOLE | 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-04-15 | 2022-01-28 | 137544 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2021-04-15 | 2021-05-20 | 137541 |
| TEVA-TRIACOMB | 1MG 100000UNIT 2.5MG 0.25MG | CREAM | Resolved | 2021-04-15 | 2021-11-18 | 137538 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
| GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |
| EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
| CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
| CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
| CLOXACILLIN SODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14014 |
| TEVA-PRAMIPEXOLE | 1.5MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14007 |